More importantly, the combinations of sustained PD-L1 blockade to the PLK1122/Sur20DC_TriVax resulted in remarkable enhanced anti-tumour effects, in which the majority of the mice achieved complete tumour eradication of heterogeneous C1498 myeloid leukaemia (Fig. 6). Here, CD274 is linked to myeloid leukemia.